rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    XERS
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Xeris Biopharma Holdings (XERS) Stock May Be Worth More Following Raised Revenue Guidance
      Nov 18Yahoo FinanceXERS
      Xeris at jefferies global healthcare conference: growth outlook rises
      Nov 17Investing.comXERSJEF
      Top 3 Health Care Stocks That May Collapse This Month
      Nov 16BenzingaXERS
      Xeris Biopharma: Time For A Pause (NASDAQ:XERS)
      Nov 12Seeking AlphaXERS
      Xeris Biopharma Holdings stock hits 52-week high at 16.64 USD
      Nov 12Investing.comXERS
      Why Did AAPL, XERS, ZETA Stocks Jump To 52-Week Highs Today?
      Nov 12Yahoo FinanceXERSZETA
      XERS, CARL Stocks Hit All-Time Highs Today – Here’s What Analysts Are Saying
      Nov 11Yahoo FinanceXERS
      Hunting for the Next Biopharma Stock to Surge 700%

      Precigen has the same combination that made Xeris work: a fast-growing product and a pipeline the market isn’t pricing in.

      Nov 9TheStreetPGENXERS
      Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?
      Nov 9Yahoo FinanceMRNAXERS
      Why Xeris Biopharma Holdings (XERS) Is Up 16.2% And What's Next

      Xeris Biopharma reported Q3 2026 revenue of US$107.23 million and net income of US$11.29 million, and then raised full year 2026 revenue guidance to between US$395 million and US$405 million after strong Recorlev demand. The business remained in a loss position over the first nine months of 2026 despite higher sales, which keeps execution, spending discipline, and product concentration in focus for anyone tracking the sustainability of this upswing. This section now looks at how Xeris...

      Nov 7Yahoo FinanceXERS
      Is Xeris Biopharma Holdings (XERS) Overpriced After Its Q3 Beat And 2026 Outlook Raise?
      Nov 7Yahoo FinanceXERS
      Xeris Biopharma (XERS) Adds Menassie M. Taddese To Its Board

      Xeris Biopharma Holdings (NasdaqGS:XERS) has appointed Menassie M. Taddese to its Board of Directors. Taddese brings nearly 30 years of global biopharma experience, including senior roles at Viatris and Pfizer. His background spans commercial operations, business transformation, and financial oversight across multiple international markets. The new Board appointment of Menassie M. Taddese is only part of Xeris Biopharma's wider investment story. Our analysis turns up 1 warning sign for Xeris...

      Nov 7Yahoo FinanceXERS
      Xeris Biopharma Q3 Earnings Call Highlights
      Nov 6Yahoo FinanceXERS
      Xeris Biopharma Holdings Inc (XERS) (Q3 2026) Earnings Call Highlights: Revenue Surges 44% as ...
      Nov 6Yahoo FinanceXERS
      Xeris Biopharma Holdings, Inc. Q3 2026 Earnings Call Summary
      Nov 5Yahoo FinanceXERS
      Xeris Pharma stock climbs on Q3 beat (XERS:NASDAQ)

      Xeris Pharmaceuticals (XERS) stock hits a 52-week high as the company posts better than expected financials and raises its outlook. Read more here.

      Nov 5Seeking AlphaXERS
      Xeris Biopharma stock hits 52-week high at 12.53 USD
      Nov 5Investing.comXERS
      Xeris Biopharma Holdings Q3 2026 Earnings Call Transcript
      Nov 5BenzingaXERS
      Xeris CEO Sees Recorlev Nearing $1B In Annual Sales 3 To 4 Years Earlier Than Expected – XERS Stock On Track To Hit Over 7-Year Highs
      Nov 5Yahoo FinanceXERS
      Xeris Biopharma (XERS) Surpasses Q3 Earnings and Revenue Estimates
      Nov 5Yahoo FinanceXERS
      Xeris Biopharma (XERS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
      Nov 5Yahoo FinanceXERS
      Xeris Biopharma: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceXERS
      Xeris Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
      Nov 5Yahoo FinanceXERS
      Xeris Biopharma legal chief Hecht sells $255,827 in stock
      Nov 5Investing.comXERS
      Xeris Biopharma COO Kevin McCulloch sells $153,487 in shares
      Nov 5Investing.comXERS
      Xeris faces earnings test after profit expectations fade
      Nov 4Investing.comXERS
      Xeris Biopharma appoints Menassie Taddese to board
      Nov 2Investing.comXERS
      Xeris Biopharma Welcomes Menassie M. Taddese to Board of Directors
      Nov 2MorningstarXERS
      Xeris Biopharma to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
      Oct 22Yahoo FinanceXERS
      Xeris Biopharma stock hits 52-week high at 11.38 USD
      Oct 19Investing.comXERS
      Xeris Biopharma presents data on endocrine therapies at fall meetings
      Oct 15Investing.comXERS
      Xeris Biopharma Reinforces Leadership in Endocrinology With Data Disclosures Spanning Commercial Portfolio and Pipeline at Multiple Scientific Meetings
      Oct 15Yahoo FinanceXERS
      Xeris Biopharma COO McCulloch sells $141,120 in shares
      Oct 13Investing.comXERS
      Xeris Biopharma CFO Steven Pieper sells $47,036 in stock
      Oct 13Investing.comXERS
      Xeris Biopharma CLO Beth Hecht sells $156,792 in XERS shares
      Oct 13Investing.comXERS
      Why Xeris Biopharma Holdings (XERS) Is Up 5.8% After Raising 2026 Revenue Guidance And Retiring Debt
      Oct 8Yahoo FinanceXERS
      Full Transcript: Xeris Biopharma Holdings Q2 2026 Earnings Call - Xeris Biopharma Holdings (NASDAQ:XERS)

      Xeris Biopharma Holdings (NASDAQ:XERS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive

      Oct 6BenzingaXERS
      Update: Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition
      Sep 30Yahoo FinanceXERS
      Xeris Biopharma Holdings Insider Sold Shares Worth $250,000, According to a Recent SEC Filing
      Sep 29Yahoo FinanceXERS
      Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports
      Sep 29Investing.comXERS
      Xeris Biopharma Reportedly Draws Takeover Interest — But Firm Says It’s ‘Not For Sale’

      According to a Bloomberg report, Danish company Lundbeck has been working with advisers to explore a potential takeover of Xeris.

      Sep 29Yahoo FinanceXERS
      Lundbeck expresses interest in buying Xeris, Bloomberg News reports
      Sep 29Yahoo FinanceXERS
      Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition
      Sep 29Yahoo FinanceXERS
      Lundbeck Is Said to Express Interest in Buying Xeris Biopharma
      Sep 29BloombergXERS
      Xeris Biopharma stock hits 52-week high at 10.08 USD
      Sep 29Investing.comXERS
      H.C. Wainwright Remains a Buy on Xeris Pharmaceuticals (XERS)

      Detailed price information for Xeris Pharmaceuticals Inc (XERS-Q) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailXERS
      Xeris at H.C. Wainwright conference: growth engine widens
      Sep 14Investing.comXERS
      Xeris Biopharma Holdings, Inc. (XERS) Discusses XP-8121 Program Overview, Phase 3 Study Details and Commercial Strategy - Slideshow (NASDAQ:XERS) 2026-09-11
      Sep 11Seeking AlphaXERS
      Oppenheimer reiterates Xeris Pharmaceuticals stock rating on XP-8121 outlook
      Sep 10Investing.comXERS
      Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism

      CHICAGO, September 09, 2026--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, will host an XP-8121 Program Overview today at 10 a.m. ET detailing a comprehensive clinical development strategy, including Cornerstone, its Phase 3 registrational study design, as well as the commercial opportunity for XP-8121, its investigational once-weekly s

      Sep 9Yahoo FinanceXERS

      This is the newest page. Registered accounts read further back.